Atlas Trials

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Clinical trial NCT03513549 · SUSPENDED

Trial details

NCT number
NCT03513549
Sponsor
Alexza Pharmaceuticals, Inc.
Status
SUSPENDED
Study type
OBSERVATIONAL
Agitation,Psychomotor
Start date
2014-11-04
Primary completion
2027-02-01
Enrollment
10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.